MENU
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ImmunityBio (IBRX) Earnings Date & Reports
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
IBRX is expected to report earnings to fall 63.64% to -7 cents per share on November 03
Q3'26
Est.
$-0.08
Q2'26
Missed
by $0.14
Q1'26
Missed
by $0.55
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.04
The last earnings report on August 04 showed earnings per share of -21 cents, missing the estimate of -7 cents. With 7.02M shares outstanding, the current market capitalization sits at 9.15B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a producer of cancer treatment products
Industry Biotechnology
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
691
Web
https://www.immunitybio.com